970 Rittenhouse Road Eagleville PA
|
19403
|
(Address of principal executive offices)
|
(Zip code)
|
ITEM 1.
|
REPORTS TO SHAREHOLDERS
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
Information About Your Fund’s Expenses
|
1-2
|
Schedule of Investments
|
3-5
|
Statement of Assets and Liabilities
|
6
|
Statement of Operations
|
7
|
Statements of Changes in Net Assets
|
8
|
Per Share Data
|
9-11
|
Notes to the Financial Statements
|
12-18
|
Additional Information
|
19-22
|
Directors and Officers Information
|
23
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
Actual Fund Return (in parentheses)
|
Beginning
Account Value
06/01/13
|
Ending
Account Value
11/30/13
|
Expenses Paid
During Period*
|
Amidex35TM Israel Mutual Fund No-Load Class (+10.88%)
|
$1,000.00
|
$1,108.80
|
$18.24
|
Amidex35TM Israel Mutual Fund Class A (+10.85%)
|
1,000.00
|
1,108.50
|
18.24
|
Amidex35TM Israel Mutual Fund Class C (+10.41%)
|
1,000.00
|
1,052.05
|
22.15
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
Hypothetical 5% Fund Return
|
Beginning
Account Value
06/01/13
|
Ending
Account Value
11/30/13
|
Expenses Paid
During Period*
|
Amidex35TM Israel Mutual Fund No-Load Class
|
$1,000.00
|
$1,003.89
|
$17.36
|
Amidex35TM Israel Mutual Fund Class A
|
1,000.00
|
1,007.77
|
17.36
|
Amidex35TM Israel Mutual Fund Class C
|
1,000.00
|
1,002.01
|
21.10
|
*
|
Expenses are equal to the Funds’ annualized expense ratios of 3.45%, 3.45% and 4.20% for the Amidex35TM Israel Mutual Fund No-Load Class, Class A and Class C shares, respectively, multiplied by the average account value over the period, multiplied by 183/365 to reflect the one-half year period.
|
Total Fund operating expense ratios as stated in the current Fund prospectus dated September 30, 2013 were as follows:
|
|
AMIDEX35TM Israel Mutual Fund Class No-Load
|
3.47%
|
AMIDEX35TM Israel Mutual Fund Class A
|
3.47%
|
AMIDEX35TM Israel Mutual Fund Class C
|
4.22%
|
Total Gross Operating Expenses (Annualized) for the six month period ended November 30, 2013 were 3.45% for the AMIDEX35TM Israel Mutual Fund Class No-Load shares, 3.45% for the AMIDEX35TM Israel Mutual Fund Class A shares and 4.20% for the AMIDEX35TM Israel Mutual Fund Class C shares. Please see the Information About Your Fund’s Expenses, the Financial Highlights and Notes to Financial Statements (Note 4) sections of this report for expense related disclosures during the six month period ended November 30, 2013.
|
AMIDEXTM Funds, Inc.
|
|||
AMIDEX35TM ISRAEL MUTUAL FUND
|
|||
SCHEDULE OF INVESTMENTS
|
|||
November 30, 2013 (Unaudited)
|
SEMI-ANNUAL REPORT
|
Shares
|
Fair Value
|
|||||||
ISRAEL – 53.05%
|
||||||||
COMMON STOCK – 53.05%
|
||||||||
Banks- 18.05%
|
||||||||
Bank Hapoalim BM
|
152,528 | $ | 850,481 | |||||
Bank Leumi Le-Israel BM *
|
170,616 | 694,128 | ||||||
First International Bank of Israel Ltd.
|
10,000 | 162,309 | ||||||
Israel Discount Bank Ltd. *
|
165,810 | 336,346 | ||||||
Mizrahi Tefahot Bank Ltd.
|
34,915 | 442,100 | ||||||
2,485,364 | ||||||||
Chemicals – 6.40%
|
||||||||
Israel Chemicals Ltd.
|
103,335 | 880,708 | ||||||
Computers – 0.44%
|
||||||||
LivePerson, Inc. *
|
5,000 | 60,827 | ||||||
Diversified Holdings – 7.69%
|
||||||||
Delek Group Ltd.
|
1,564 | 591,889 | ||||||
Israel Corp. Ltd. *
|
908 | 466,851 | ||||||
1,058,740 | ||||||||
Food – 5.56%
|
||||||||
Osem Investments Ltd.
|
19,084 | 438,266 | ||||||
Strauss Group Ltd.
|
17,900 | 327,834 | ||||||
766,100 | ||||||||
Insurance- 4.01%
|
||||||||
Harel Insurance Investments & Financial Services Ltd.
|
42,000 | 241,342 | ||||||
Migdal Insurance & Financial Holdings Ltd.
|
177,216 | 310,429 | ||||||
551,771 | ||||||||
Oil & Gas – 2.43%
|
||||||||
Oil Refineries Ltd. *
|
413,000 | 130,151 | ||||||
Paz Oil Co. Ltd. *
|
1,300 | 204,284 | ||||||
334,435 | ||||||||
Real Estate – 4.62%
|
||||||||
Azrieli Group Ltd.
|
12,000 | 394,856 | ||||||
Gazit-Globe Ltd.
|
18,000 | 241,206 | ||||||
636,062 |
AMIDEXTM Funds, Inc.
|
|||||
AMIDEX35TM ISRAEL MUTUAL FUND
|
|||||
SCHEDULE OF INVESTMENTS
|
|||||
November 30, 2013 (Unaudited)
|
SEMI-ANNUAL REPORT
|
Shares
|
Fair Value
|
|||||||
ISRAEL – 53.05% (continued)
|
||||||||
COMMON STOCK – 53.05% (continued)
|
||||||||
Telecommunications – 3.85%
|
||||||||
Bezeq Israeli Telecommunication Corp. Ltd.
|
317,390 | $ | 530,740 | |||||
TOTAL COMMON STOCK – ISRAEL (Cost $4,523,127)
|
7,304,747 | |||||||
TOTAL ISRAEL (Cost $4,523,127)
|
7,304,747 | |||||||
UNITED STATES – 46.89%
|
||||||||
COMMON STOCK – 46.48%
|
||||||||
Aerospace & Defense – 3.09%
|
||||||||
Elbit Systems Ltd.
|
7,698 | 426,161 | ||||||
Computers – 0.86%
|
||||||||
Electronics for Imaging, Inc. *
|
3,000 | 118,800 | ||||||
Electric – 1.64%
|
||||||||
Ormat Technologies, Inc.
|
9,000 | 225,720 | ||||||
Household Products & Wares – 0.84%
|
||||||||
SodaStream International Ltd. *
|
2,000 | 114,960 | ||||||
Pharmaceuticals – 12.28 %
|
||||||||
Taro Pharmaceutical Industries Ltd. *
|
5,000 | 475,000 | ||||||
Teva Pharmaceutical Industries Ltd. - ADR
|
29,816 | 1,215,300 | ||||||
1,690,300 | ||||||||
Semiconductors – 1.41%
|
||||||||
Mellanox Technologies Ltd. *
|
5,000 | 194,700 | ||||||
Software – 14.20%
|
||||||||
Check Point Software Technologies Ltd. *
|
21,695 | 1,342,053 | ||||||
VeriFone Systems, Inc. *
|
14,000 | 358,540 | ||||||
Verint Systems, Inc. *
|
6,721 | 254,861 | ||||||
1,955,454 | ||||||||
Telecommunications – 10.22%
|
||||||||
Amdocs Ltd.
|
19,803 | 801,229 | ||||||
Cellcom Israel Ltd.
|
18,500 | 252,155 | ||||||
NICE Systems Ltd. - ADR
|
9,000 | 354,240 | ||||||
1,407,624 | ||||||||
Wireless Telecommunication Services – 1.94%
|
||||||||
Partner Communications Co., Ltd. – ADR *
|
28,100 | 267,512 | ||||||
TOTAL COMMON STOCK – UNITED STATES (Cost $5,652,498)
|
6,401,231 |
AMIDEXTM Funds, Inc.
|
|||
AMIDEX35TM ISRAEL MUTUAL FUND
|
|||
SCHEDULE OF INVESTMENTS
|
|||
November 30, 2013 (Unaudited)
|
SEMI-ANNUAL REPORT
|
Shares
|
Fair Value
|
|||||||
UNITED STATES – 46.89% (continued)
|
||||||||
SHORT-TERM INVESTMENTS – 0.41%
|
||||||||
Fidelity Institutional Money Market Fund, 0.01% ** (Cost $56,880)
|
56,880 | $ | 56,880 | |||||
TOTAL UNITED STATES (Cost $5,709,378)
|
$ | 6,458,111 | ||||||
TOTAL INVESTMENTS (Cost $10,232,505) – 99.94%
|
$ | 13,762,858 | ||||||
OTHER ASSETS LESS LIABILITIES, NET – 0.06%
|
7,614 | |||||||
NET ASSETS - 100.00%
|
$ | 13,770,472 |
*
|
Non-income producing security.
|
**
|
Rate shown represents the rate at November 30, 2013, is subject to change and resets daily.
|
ADR
|
- American Depository Receipt.
|
BM
|
- Beeravon Mugbal (Limited).
|
SEMI-ANNUAL REPORT
|
|||||||||||
STATEMENT OF ASSETS AND LIABILITIES – November 30, 2013 (Unaudited)
|
AMIDEX35TM
Israel Mutual Fund
|
||||
Assets:
|
||||
Investments, at fair value (cost: $10,232,505)
|
$ | 13,762,858 | ||
Receivables:
|
||||
Dividends
|
18,808 | |||
Fund shares sold
|
3,500 | |||
Prepaid expenses
|
40,754 | |||
Total assets
|
13,825,920 | |||
Liabilities:
|
||||
Payables:
|
||||
Fund shares redeemed
|
2,534 | |||
Investment advisory and administrative fees
|
9,333 | |||
Distribution fees
|
6,676 | |||
Fund accounting and transfer agency fees
|
10,250 | |||
Other liabilities and accrued expenses
|
26,655 | |||
Total liabilities
|
55,448 | |||
Net Assets
|
$ | 13,770,472 | ||
Net Assets consist of:
|
||||
Common stock
|
$ | 106 | ||
Additional paid-in capital
|
16,513,565 | |||
Accumulated net investment loss
|
(183,842 | ) | ||
Accumulated realized loss on investments
|
(6,089,715 | ) | ||
Net unrealized appreciation on investments
|
3,530,358 | |||
Total Net Assets (1,061,200 shares outstanding; 500,000,000 shares of $0.0001 par value authorized for the Fund)
|
$ | 13,770,472 | ||
No-load class shares:
|
||||
Net Assets applicable to 793,013 shares outstanding
|
$ | 11,318,091 | ||
Net Asset Value and offering price per share
|
$ | 14.27 | ||
Minimum Redemption price per share No-load class 1
|
$ | 13.98 | ||
Class A shares:
|
||||
Net Assets applicable to 117,993 shares outstanding
|
$ | 1,289,975 | ||
Net Asset Value and redemption price per share
|
$ | 10.93 | ||
Maximum Offering price per share Class A 2
|
$ | 11.57 | ||
Class C shares:
|
||||
Net Assets applicable to 150,194 shares outstanding
|
$ | 1,162,406 | ||
Net Asset Value and offering price per share
|
$ | 7.74 | ||
Minimum Redemption price per share Class C 3
|
$ | 7.66 |
1
|
A redemption fee of 2.00% is imposed on redemptions occurring within 365 days of purchase.
|
||||||||||
2
|
A maximum sales charge of 5.50% is imposed on Class A shares.
|
||||||||||
3
|
A contingent deferred sales charge (“CDSC”) of 1.00% is imposed in the event of certain redemption transactions within thirteen months following such investments.
|
AMIDEXTM Funds, Inc. |
SEMI-ANNUAL REPORT
|
|||
STATEMENT OF OPERATIONS
|
AMIDEX35TM
|
||||
Israel Mutual Fund
|
||||
|
For the
Six Month
Period Ended
November 30, 2013
|
|||
(Unaudited)
|
||||
Investment income:
|
||||
Dividends (net of foreign withholding taxes of $34,417)
|
$ | 137,319 | ||
Interest
|
3 | |||
Total investment income
|
137,322 | |||
Expenses:
|
||||
Investment advisory fees
|
51,130 | |||
Distribution fees - No-load Class
|
13,183 | |||
Distribution fees - Class A
|
1,494 | |||
Distribution fees - Class C
|
5,203 | |||
Fund accounting and transfer agent fees
|
61,500 | |||
Registration fees
|
19,814 | |||
Legal fees
|
15,542 | |||
Custody fees (a)
|
11,031 | |||
Audit fees
|
9,827 | |||
Miscellaneous
|
9,077 | |||
Out of pocket expenses
|
7,690 | |||
Networking fees
|
6,518 | |||
Administrative fees
|
6,391 | |||
Trustee fees
|
2,507 | |||
Pricing fees
|
2,008 | |||
Insurance fees
|
1,627 | |||
Total expenses
|
224,542 | |||
Net investment loss
|
(87,220 | ) | ||
|
||||
Realized and unrealized gain on investments and foreign currency transactions:
|
||||
Net realized gain on investments and foreign currency transactions
|
11,971 | |||
Net change in unrealized appreciation on investments and foreign currency transactions
|
1,422,092 | |||
Net realized and unrealized gain on investments and foreign currency transactions
|
1,434,063 | |||
Net increase in net assets resulting from operations
|
$ | 1,346,843 |
(a)
|
Includes interest credits of $15
|
SEMI-ANNUAL REPORT
|
||||||
STATEMENTS OF CHANGES IN NET ASSETS
|
AMIDEX35TM Israel Mutual Fund
|
||||||||
For the
Six Month
Period Ended
November 30, 2013
|
For the
Year Ended
May 31, 2013
|
|||||||
Increase (decrease) in Net Assets
|
(Unaudited)
|
|||||||
Operations:
|
||||||||
Net investment loss
|
$ | (87,220 | ) | $ | (211,161 | ) | ||
Net realized gain (loss) on investments and foreign currency transactions
|
11,971 | (1,317,073 | ) | |||||
Net change in unrealized appreciation (depreciation) on investments and foreign currency transactions
|
1,422,092 | 3,076,190 | ||||||
Net increase in net assets resulting from operations
|
1,346,843 | 1,547,956 | ||||||
Decrease in net assets from Fund share transactions (Note 2)
|
(142,513 | ) | (1,531,987 | ) | ||||
Total increase in net assets
|
1,204,330 | 15,969 | ||||||
Net Assets:
|
||||||||
Beginning of year/period
|
12,566,142 | 12,550,173 | ||||||
End of year/period
|
$ | 13,770,472 | $ | 12,566,142 | ||||
Undistributed Accumulated net investment loss
|
$ | (183,842 | ) | $ | (96,622 | ) |
The accompanying notes are an integral part of these financial statements.
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
||||||||||||||||||
FINANCIAL HIGHLIGHTS
|
|||||||||||||||||||
Per Share Data For a Share Outstanding Throughout Each Fiscal Period or Year
|
AMIDEX35TM Israel Mutual Fund | |||||||||||||||||||||||||
No-Load Class | |||||||||||||||||||||||||
|
For the
Six Months Ended
November 30, 2013 |
For the
Year Ended
May 31, 2013 |
For the
Year Ended
May 31, 2012
|
For the
Year Ended
May 31, 2011
|
For the
Year Ended
May 31, 2010
|
For the
Year Ended
May 31, 2009
|
|||||||||||||||||||
(Unaudited)
|
|||||||||||||||||||||||||
Net Asset Value, Beginning of
Period or Year
|
$ | 12.87 | $ | 11.35 | $ | 16.94 | $ | 13.93 | $ | 11.98 | $ | 17.80 | |||||||||||||
Investment Operations:
|
|||||||||||||||||||||||||
Net investment income (loss) (a)
|
(0.09 | ) | (0.20 | ) | (0.10 | ) | 0.05 | (0.05 | ) | (0.06 | ) | ||||||||||||||
Net realized and unrealized
|
|||||||||||||||||||||||||
gain (loss) on investments
|
1.49 | 1.72 | (5.50 | ) | 2.99 | 1.99 | (5.78 | ) | |||||||||||||||||
Total from investment
|
|||||||||||||||||||||||||
operations
|
1.40 | 1.52 | (5.60 | ) | 3.04 | 1.94 | (5.84 | ) | |||||||||||||||||
Distributions:
|
|||||||||||||||||||||||||
From net investment income
|
- | - | - | (0.05 | ) | - | - | ||||||||||||||||||
Total distributions
|
- | - | - | (0.05 | ) | - | - | ||||||||||||||||||
Paid in capital from redemption fees
|
- |
(b)
|
- |
(b)
|
0.01 | 0.02 | 0.01 | 0.02 | |||||||||||||||||
Net Asset Value, End of Period or
Year
|
$ | 14.27 | $ | 12.87 | $ | 11.35 | $ | 16.94 | $ | 13.93 | $ | 11.98 | |||||||||||||
Total Return (c)
|
10.88 | % |
(d)
|
13.39 | % | (33.00 | )% | 21.93 | % | 16.28 | % | (32.70 | )% | ||||||||||||
Ratios/Supplemental Data
|
|||||||||||||||||||||||||
Net assets, end of period or year
(in 000’s)
|
$ | 11,318 | $ | 10,415 | $ | 9,849 | $ | 15,821 | $ | 14,432 | $ | 11,088 | |||||||||||||
Ratio of expenses to average net assets:
|
3.45 | % |
(e)
|
3.47 | % | 3.02 | % | 2.62 | % | 2.84 | % | 3.24 | % | ||||||||||||
Ratio of net investment income (loss)
|
|||||||||||||||||||||||||
to average net assets:
|
(1.30 | )% |
(e)
|
(1.63 | )% | (0.75 | )% | 0.31 | % | (0.32 | )% | (0.47 | )% | ||||||||||||
Portfolio turnover rate
|
0.00 | % | 7.98 | % | 1.29 | % | 4.06 | % | 2.56 | % | 2.08 | % |
(a)
|
Net investment income (loss) per share is based on average shares outstanding.
|
(b)
|
Redemption fees resulted in less than $0.01 per share.
|
(c)
|
Total return in the above table represents the rate that the investor would have earned or lost on an investment in the Fund assuming reinvestment of dividends.
|
(d)
|
Aggregate total return, not annualized.
|
(e)
|
Annualized.
|
The accompanying notes are an integral part of these financial statements.
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
|||||||||
FINANCIAL HIGHLIGHTS
|
||||||||||
Per Share Data For a Share Outstanding Throughout Each Fiscal Period or Year
|
AMIDEX35TM Israel Mutual Fund
|
||||||||||||||||||||||||
Class A
|
||||||||||||||||||||||||
|
For the
Six Months
Ended
November
30, 2013
|
For the
Year Ended
May 31, 2013
|
For the
Year Ended
May 31,
2012
|
For the
Year Ended
May 31, 2011
|
For the
Year Ended
May 31, 2010 |
For the
Year Ended
May 31, 2009
|
||||||||||||||||||
(Unaudited)
|
||||||||||||||||||||||||
Net Asset Value, Beginning of
Period or Year
|
$ | 9.86 | $ | 8.70 | $ | 12.99 | $ | 10.71 | $ | 9.22 | $ | 13.73 | ||||||||||||
Investment Operations:
|
||||||||||||||||||||||||
Net investment income (loss) (a)
|
(0.07 | ) | (0.16 | ) | (0.08 | ) | 0.04 | (0.04 | ) | (0.04 | ) | |||||||||||||
Net realized and unrealized
|
||||||||||||||||||||||||
gain (loss) on investments
|
1.14 | 1.32 | (4.21 | ) | 2.30 | 1.53 | (4.47 | ) | ||||||||||||||||
Total from investment
|
||||||||||||||||||||||||
operations
|
1.07 | 1.16 | (4.29 | ) | 2.34 | 1.49 | (4.51 | ) | ||||||||||||||||
Distributions:
|
||||||||||||||||||||||||
From net investment income
|
- | - | - | (0.06 | ) | - | - | |||||||||||||||||
Total distributions
|
- | - | - | (0.06 | ) | - | - | |||||||||||||||||
Net Asset Value, End of Period or
Year
|
$ | 10.93 | $ | 9.86 | $ | 8.70 | $ | 12.99 | $ | 10.71 | $ | 9.22 | ||||||||||||
Total Return (b)
|
10.85 | % |
(c)
|
13.33 | % | (33.03 | )% | 21.81 | % | 16.16 | % | (32.85 | )% | |||||||||||
Ratios/Supplemental Data
|
||||||||||||||||||||||||
Net assets, end of period or year
(in 000’s)
|
$ | 1,290 | $ | 1,158 | $ | 1,698 | $ | 3,833 | $ | 3,265 | $ | 2,393 | ||||||||||||
Ratio of expenses to average net assets:
|
3.45 | % |
(d)
|
3.47 | % | 3.02 | % | 2.62 | % | 2.85 | % | 3.23 | % | |||||||||||
Ratio of net investment income (loss)
|
||||||||||||||||||||||||
to average net assets:
|
(1.30 | )% |
(d)
|
(1.63 | )% | (0.75 | )% | 0.30 | % | (0.34 | )% | (0.48 | )% | |||||||||||
Portfolio turnover rate
|
0.00 | % | 7.98 | % | 1.29 | % | 4.06 | % | 2.56 | % | 2.08 | % |
(a)
|
Net investment income (loss) income per share is based on average shares outstanding.
|
(b)
|
Total return in the above table represents the rate that the investor would have earned or lost on an investment in the Fund assuming reinvestment of dividends.
|
(b)
|
Aggregate total return, not annualized.
|
(d)
|
Annualized.
|
The accompanying notes are an integral part of these financial statements.
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
||||||||||
FINANCIAL HIGHLIGHTS
|
|||||||||||
Per Share Data For a Share Outstanding Throughout Each Fiscal Period or Year
|
AMIDEX35TM Israel Mutual Fund
|
||||||||||||||||||||||||
Class C
|
||||||||||||||||||||||||
|
For the
Six Months
Ended
November 30, 2013
|
For the
Year Ended
May 31, 2013
|
For the
Year Ended
May 31, 2012
|
For the
Year Ended
May 31, 2011
|
For the
Year Ended
May 31, 2010
|
For the
Year Ended
May 31, 2009
|
||||||||||||||||||
(Unaudited)
|
||||||||||||||||||||||||
Net Asset Value, Beginning of
Period or Year
|
$ | 7.01 | $ | 6.23 | $ | 9.37 | $ | 7.76 | $ | 6.73 | $ | 10.09 | ||||||||||||
Investment Operations:
|
||||||||||||||||||||||||
Net investment loss (a)
|
(0.07 | ) | (0.16 | ) | (0.11 | ) | (0.04 | ) | (0.08 | ) | (0.08 | ) | ||||||||||||
Net realized and unrealized
|
||||||||||||||||||||||||
gain (loss) on investments
|
0.80 | 0.94 | (3.03 | ) | 1.65 | 1.11 | (3.28 | ) | ||||||||||||||||
Total from investment
|
||||||||||||||||||||||||
operations
|
0.73 | 0.78 | (3.14 | ) | 1.61 | 1.03 | (3.36 | ) | ||||||||||||||||
Net Asset Value, End of Period or
Year
|
$ | 7.74 | $ | 7.01 | $ | 6.23 | $ | 9.37 | $ | 7.76 | $ | 6.73 | ||||||||||||
Total Return (b)
|
10.41 | % |
(c)
|
12.52 | % | (33.51 | )% | 20.81 | % | 15.30 | % | (33.30 | )% | |||||||||||
Ratios/Supplemental Data
|
||||||||||||||||||||||||
Net assets, end of period or year
(in 000’s)
|
$ | 1,162 | $ | 993 | $ | 1,003 | $ | 1,581 | $ | 1,195 | $ | 746 | ||||||||||||
Ratio of expenses to average net assets:
|
4.20 | % |
(d)
|
4.22 | % | 3.77 | % | 3.37 | % | 3.58 | % | 3.98 | % | |||||||||||
Ratio of net investment loss to
|
||||||||||||||||||||||||
average net assets:
|
(2.05 | )% |
(d)
|
(2.38 | )% | (1.50 | )% | (0.47 | )% | (1.03 | )% | (1.23 | )% | |||||||||||
Portfolio turnover rate
|
0.00 | % | 7.98 | % | 1.29 | % | 4.06 | % | 2.56 | % | 2.08 | % |
(a)
|
Net investment loss per share is based on average shares outstanding.
|
(b)
|
Total return in the above table represents the rate that the investor would have earned or lost on an investment in the Fund assuming reinvestment of dividends.
|
(c)
|
Aggregate total return, not annualized.
|
(d)
|
Annualized.
|
The accompanying notes are an integral part of these financial statements.
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
1.
|
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES
|
Level 1
|
- Quoted prices in active markets for identical securities.
|
Level 2
|
- Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
|
Level 3
|
- Significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments).
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
1.
|
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (continued)
|
Security Classification (a)
|
||||
Level 1
|
||||
Common Stock - Israel (b)
|
$ | 7,304,747 | ||
Common Stock - United States (b)
|
6,401,231 | |||
Short-Term Investments
|
56,880 | |||
Total Level 1
|
$ | 13,762,858 | ||
Level 2
|
$ | - | ||
Level 3
|
$ | - | ||
Total Investments
|
$ | 13,762,858 |
(a)
|
As of and during the six month period ended November 30, 2013, the Fund held no securities that were considered to be “Level 3” securities (those valued using significant unobservable inputs). Therefore, a reconciliation of assets in which significant unobservable inputs (Level 3) were used in determining fair value is not applicable.
|
(b)
|
All common stocks held in the Fund are Level 1 securities. For a detailed break-out of common stocks by major industry classification, please refer to the Schedule of Investments.
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
1.
|
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (continued)
|
2.
|
CAPITAL SHARE TRANSACTIONS
|
No-Load
|
||||||||
Shares
|
Amount
|
|||||||
Sold
|
17,406 | $ | 232,702 | |||||
Redeemed
|
(33,661 | ) | (441,117 | ) | ||||
Net Decrease
|
(16,255 | ) | $ | (208,415 | ) |
Class A
|
||||||||
Shares
|
Amount
|
|||||||
Sold
|
6,959 | $ | 70,370 | |||||
Redeemed
|
(6,465 | ) | (65,798 | ) | ||||
Net Increase
|
494 | $ | 4,572 |
Class C
|
||||||||
Shares
|
Amount
|
|||||||
Sold
|
14,159 | $ | 103,529 | |||||
Redeemed
|
(5,750 | ) | (42,199 | ) | ||||
Net Increase
|
8,409 | $ | 61,330 |
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
2.
|
CAPITAL SHARE TRANSACTIONS (continued)
|
No-Load
|
||||||||
Shares
|
Amount
|
|||||||
Sold
|
48,378 | $ | 593,888 | |||||
Redeemed
|
(106,518 | ) | (1,279,627 | ) | ||||
Net Decrease
|
(58,140 | ) | $ | (685,739 | ) |
Class A
|
||||||||
Shares
|
Amount
|
|||||||
Sold
|
12,831 | $ | 111,560 | |||||
Redeemed
|
(90,479 | ) | (830,985 | ) | ||||
Net Decrease
|
(77,648 | ) | $ | (719,425 | ) |
Class C
|
||||||||
Shares
|
Amount
|
|||||||
Sold
|
15,282 | $ | 101,919 | |||||
Redeemed
|
(34,609 | ) | (228,742 | ) | ||||
Net Decrease
|
(19,327 | ) | $ | (126,823 | ) |
3.
|
INVESTMENT TRANSACTIONS
|
Purchases
|
Sales
|
|||||
$ | - | $ | 343,588 |
4.
|
ADVISORY FEES AND OTHER RELATED PARTY TRANSACTIONS
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
4.
|
ADVISORY FEES AND OTHER RELATED PARTY TRANSACTIONS (continued)
|
5.
|
TAX MATTERS
|
Cost
|
Gross
Appreciation
|
Gross
Depreciation
|
Net
Appreciation
|
|||
$10,891,737
|
$5,101,451
|
$(2,230,330)
|
$2,871,121
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
5.
|
TAX MATTERS (continued)
|
Unrealized Appreciation
|
$ | 1,438,474 | ||
Capital Loss Carryforwards
|
(3,986,717 | ) | ||
Post-October Capital Losses
|
(1,445,177 | ) | ||
Post-December Ordinary Losses
|
(96,622 | ) | ||
Total Distributable Earnings, Net
|
$ | (4,090,042 | ) |
Post-October Losses
|
Post-December Losses
|
|||
Deferred
|
Utilized
|
Deferred
|
Utilized
|
|
$1,445,177
|
$500,643
|
$96,622
|
$92,652
|
Expiring in: 2014
|
$ | (1,409,903 | ) | |
2015
|
(1,009,874 | ) | ||
2016
|
(652,905 | ) | ||
2017
|
(393,230 | ) | ||
2018
|
(51,633 | ) | ||
No Expiration – Long-Term
|
(469,172 | ) | ||
$ | (3,986,717 | ) |
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
6.
|
CONCENTRATION OF RISK
|
7.
|
BENEFICIAL OWNERSHIP
|
8.
|
COMMITMENTS AND CONTINGENCIES
|
9.
|
RECENT ACCOUNTING PROUNOUNCEMENTS
|
10.
|
SUBSEQUENT EVENTS
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
AMIDEXTM Funds, Inc.
|
SEMI-ANNUAL REPORT
|
Name of Director1
|
Aggregate Compensation
From the Company2
|
Pension or Retirement
Benefits Accrued As Part of
Portfolio Expenses
|
Estimated Annual Benefits Upon Retirement
|
Total Compensation From the Company
Paid to Directors2
|
Independent Directors
|
||||
Eli Gabay, Esq.
|
$2,000
|
None
|
None
|
$2,000
|
Erica Levi
|
$2,000
|
None
|
None
|
$2,000
|
Interested Officers
|
||||
Clifford A. Goldstein
|
None
|
Not Applicable
|
Not Applicable
|
None
|
Larry E. Beaver, Jr.
|
None
|
Not Applicable
|
Not Applicable
|
None
|
1
|
Each of the Directors and Officers serves as a Director or Officer to the one portfolio of the Company.
|
2
|
Figures are for the six month period ended November 30, 2013.
|
FOR MORE INFORMATION
|
Visit Our Website:
|
www.amidex.com
|
Email:
|
info@amidex.com
|
Call Us Toll Free:
|
1-888-876-3566
|
ITEM 2.
|
CODE OF ETHICS.
|
ITEM 3.
|
AUDIT COMMITTEE FINANCIAL EXPERT.
|
ITEM 4.
|
PRINCIPAL ACCOUNTANT FEES AND SERVICES.
|
ITEM 5.
|
AUDIT COMMITTEE OF LISTED REGISTRANTS.
|
ITEM 6.
|
SCHEDULE OF INVESTMENT
|
ITEM 7.
|
DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
|
ITEM 8.
|
PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES
|
ITEM 9.
|
PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.
|
ITEM 10.
|
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
|
ITEM 11.
|
CONTROLS AND PROCEDURES.
|
|
(a)
|
The registrant's principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the 1940 Act, are effective, as of a date within 90 days of the filing date of this report, based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rule 15d-15(b) under the Securities Exchange Act of 1934, as amended.
|
|
(b)
|
There were no changes in the registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant's internal control over financial reporting.
|
ITEM 12.
|
EXHIBITS
|
|
(1)
|
Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 are filed herewith.
|
|
(2)
|
Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are filed herewith.
|
/s/ Clifford A. Goldstein | |
By Clifford A. Goldstein
|
|
President,
|
|
Date: January 24, 2014
|
/s/ Clifford A. Goldstein | |
By Clifford A. Goldstein
|
|
President
|
|
Date: January 24, 2014
|
/s/ Larry E. Beaver, Jr. | |
By Larry E. Beaver, Jr.
|
|
Chief Accounting Officer
|
|
Date: January 24, 2014
|
|
1.
|
I have reviewed this report on Form N-CSR of the AMIDEX Funds, Inc. (the “registrant”);
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal period for which the report is filed;
|
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3 (d) under the Investment Company Act of 1940) for the registrant and have:
|
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles:
|
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
|
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
|
5.
|
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of Trustees (or persons performing the equivalent functions):
|
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
|
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: January 24, 2014
|
/s/ Clifford A. Goldstein
|
|
Clifford A. Goldstein
|
||
President
|
|
1.
|
I have reviewed this report on Form N-CSR of the AMIDEX Funds, Inc. (the “registrant”);
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal period for which the report is filed;
|
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3 (d) under the Investment Company Act of 1940) for the registrant and have:
|
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles:
|
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
|
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
|
5.
|
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of Trustees (or persons performing the equivalent functions):
|
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
|
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: January 24, 2014
|
/s/ Larry E. Beaver, Jr.
|
|
Larry E. Beaver, Jr.
|
||
Chief Accounting Officer
|
|
1.
|
The N-CSR of the Fund for the period ended November 30, 2013 (the "Report") fully complies with the requirements of Section 15(d) of the Securities Exchange Act of 1934; and
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
By:
|
/s/ Clifford A. Goldstein
|
|
Clifford A. Goldstein
|
||
President
|
||
Date:
|
January 24, 2014
|
|
1.
|
The N-CSR of the Fund for the period ended November 30, 2013 (the "Report") fully complies with the requirements of Section 15(d) of the Securities Exchange Act of 1934; and
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
By:
|
/s/ Larry E. Beaver, Jr.
|
|
Larry E. Beaver, Jr.
|
||
Chief Accounting Officer
|
||
Date:
|
January 24, 2014
|
D!\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B
M`JP"M@+!`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#
MH@.N`[H#QP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$
M!-,$X03P!/X%#044%]@8&!A8&
M)P8W!D@&609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L
M![\'T@?E!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)
M>0F/":0)N@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI
M"X`+F`NP"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-
MJ0W##=X-^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)
M$"800Q!A$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2
MPQ+C$P,3(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;
M%;T5X!8#%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8
MU1CZ&2`911EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ
M'%(<>QRC',P<]1T>'4<=:AZ4'KX>Z1\3'SX?:1^4'[\?
MZB`5($$@;""8(,0@\"$<(4@A=2&A( &YXS'DJ
M>8EYYWI&>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!
MS8(P@I*"](-7@[J$'82`A..%1X6KA@Z& G)E4WI.5&-Z:V,Y9"(_/B`\>#IX;7!M971A('AM
M;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R
M92`U+C`M8S`V,2`V-"XQ-#`Y-#DL(#(P,3`O,3(O,#H"1N#H
M0=/7DG+*LZPS73:,DNPA2$301*0@%*$_9^-V&P_(O7&J\:WKF6S^KQ&*P\L1
MX\3;OY"0T":KUI9QC>%:',Y,D#)55R!/#)W3&`P0LGM.;8%0<=H[I9WF?'V@
M\A:L2@U9^NBJU6M$TXD'ZDA=;XZ9+&0/*/.Z5!$ZB3)NT25634XU\3^6W`G&
M7=1RBMT/'5^1&6